help button home button Am J Pathol Angiogenesis Meeting
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Illa, I.
Right arrow Articles by Juarez, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Illa, I.
Right arrow Articles by Juarez, C.

American Journal of Pathology, Vol 151, 81-88, Copyright © 1997 by American Society for Investigative Pathology


REGULAR ARTICLES

Signal transducer and activator of transcription 1 in human muscle: implications in inflammatory myopathies

I Illa, E Gallardo, R Gimeno, C Serrano, I Ferrer and C Juarez
Department of Neurology, Hospital Universitari de la Sta Creu i Sant Pau, Barcelona, Spain.

Polymyositis (PM) and dermatomyositis (DM) are two major and distinct inflammatory myopathies. Cytokines, implicated in the immune process, have been recognized in the muscle tissue from PM and DM patients, but their functional in situ role has not been identified. We analyzed the expression of the signal transducer and activator of transcription 1 (STAT1), a molecule whose up-regulation indicates the interaction of cytokines, or growth factors, with their target receptors in muscle fibers and inflammatory infiltrates in PM and DM. An immunohistochemical analysis was performed using monoclonal antibodies to STAT1 in 57 muscle biopsies from 10 patients with DM, 10 with PM, and 37 controls. The profile of STAT1 up-regulation was also investigated in cultured muscle stimulated by interferon-gamma, epidermal growth factor, platelet-derived growth factor, and interleukin-2, using semiquantitative polymerase chain reaction and Western blot. High STAT1 expression was observed in many perifascicular atrophic muscle fibers from DM patients in 10/10 biopsies. In contrast, only a few muscle fibers undergoing necrosis were STAT1 positive in 2/10 patients with PM and in 2/37 controls. STAT1 reactivity was noted in most cells of the infiltrates in DM, PM, and controls. In vitro, STAT1 was stimulated by interferon-gamma but not by the other molecules studied. These results suggest that in DM, but not in PM, there is distinctive functional local cytokine activity able to increase STAT1 expression in muscle fibers. As interferon-gamma specifically activates STAT1 in vitro, this cytokine in conjunction with ischemia is probably involved in perifascicular muscle fiber pathology in DM.


This article has been cited by other articles:


Home page
NeurologyHome page
I. Illa, N. De Luna, R. Dominguez-Perles, R. Rojas-Garcia, C. Paradas, J. Palmer, C. Marquez, P. Gallano, and E. Gallardo
Symptomatic dysferlin gene mutation carriers: Characterization of two cases
Neurology, April 17, 2007; 68(16): 1284 - 1289.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. de Luna, E. Gallardo, M. Soriano, R. Dominguez-Perles, C. de la Torre, R. Rojas-Garcia, J. M. Garcia-Verdugo, and I. Illa
Absence of Dysferlin Alters Myogenin Expression and Delays Human Muscle Differentiation "in Vitro"
J. Biol. Chem., June 23, 2006; 281(25): 17092 - 17098.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. H. Ho and L. B. Ivashkiv
Role of STAT3 in Type I Interferon Responses: NEGATIVE REGULATION OF STAT1-DEPENDENT INFLAMMATORY GENE ACTIVATION
J. Biol. Chem., May 19, 2006; 281(20): 14111 - 14118.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
J. L. De Bleecker, B. De Paepe, I. E. Vanwalleghem, and J. M. Schroder
Differential expression of chemokines in inflammatory myopathies
Neurology, June 25, 2002; 58(12): 1779 - 1785.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Z. Tezak, E. P. Hoffman, J. L. Lutz, T. O. Fedczyna, D. Stephan, E. G. Bremer, I. Krasnoselska-Riz, A. Kumar, and L. M. Pachman
Gene Expression Profiling in DQA1*0501+ Children with Untreated Dermatomyositis: A Novel Model of Pathogenesis
J. Immunol., April 15, 2002; 168(8): 4154 - 4163.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
K. Rouger, J.-P. Louboutin, M. Villanova, Y. Cherel, and M. Fardeau
X-Linked Vacuolated Myopathy : TNF-{{alpha}} and IFN-{{gamma}} Expression in Muscle Fibers with MHC Class I on Sarcolemma
Am. J. Pathol., February 1, 2001; 158(2): 355 - 359.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. Canicio, E. Gallardo, I. Illa, X. Testar, M. Palacin, A. Zorzano, and P. Kaliman
p70 S6 Kinase Activation Is Not Required for Insulin-Like Growth Factor-Induced Differentiation of Rat, Mouse, or Human Skeletal Muscle Cells
Endocrinology, December 1, 1998; 139(12): 5042 - 5049.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the American Society for Investigative Pathology.